{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:50:12Z","timestamp":1793742612416,"version":"4.6.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12272-020-01225-2","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T05:03:58Z","timestamp":1583816638000},"page":"371-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems"],"prefix":"10.1007","volume":"43","author":[{"given":"Mohammad M.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmin","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Nu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Nazzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"issue":"2","key":"1225_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s10637-014-0189-z","volume":"33","author":"JJ Alumkal","year":"2015","unstructured":"Alumkal JJ, Slottke R, Schwartzman J, Cherala G, Munar M, Graff JN, Beer TM, Ryan CW, Koop DR, Gibbs A, Gao L, Flamiatos JF, Tucker E, Kleinschmidt R, Mori M (2015) A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest New Drugs 33(2):480\u2013489. https:\/\/doi.org\/10.1007\/s10637-014-0189-z","journal-title":"Invest New Drugs"},{"issue":"6","key":"1225_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s40495-015-0034-x","volume":"1","author":"AI Amjad","year":"2015","unstructured":"Amjad AI, Parikh RA, Appleman LJ, Hahm ER, Singh K, Singh SV (2015) Broccoli-derived sulforaphane and chemoprevention of prostate cancer: from bench to bedside. Curr Pharmacol Rep 1(6):382\u2013390","journal-title":"Curr Pharmacol Rep"},{"issue":"4","key":"1225_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3892\/ijo.2014.2539","volume":"45","author":"M Appari","year":"2014","unstructured":"Appari M, Babu KR, Kaczorowski A, Gross W, Herr I (2014) Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. Int J Oncol 45(4):1391\u20131400. https:\/\/doi.org\/10.3892\/ijo.2014.2539","journal-title":"Int J Oncol"},{"issue":"2","key":"1225_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s40495-014-0002-x","volume":"1","author":"LL Atwell","year":"2015","unstructured":"Atwell LL, Beaver LM, Shannon J, Williams DE, Dashwood RH, Ho E (2015a) Epigenetic regulation by sulforaphane: opportunities for breast and prostate cancer chemoprevention. Curr Pharmacol Rep 1(2):102\u2013111. https:\/\/doi.org\/10.1007\/s40495-014-0002-x","journal-title":"Curr Pharmacol Rep"},{"issue":"12","key":"1225_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/1940-6207.CAPR-15-0119","volume":"8","author":"LL Atwell","year":"2015","unstructured":"Atwell LL, Zhang Z, Mori M, Farris P, Vetto JT, Naik AM, Oh KY, Thuillier P, Ho E, Shannon J (2015b) Sulforaphane bioavailability and chemopreventive activity in women scheduled for breast biopsy. Cancer Prev Res (Phila) 8(12):1184\u20131191","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"1225_CR6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/cncr.32022","volume":"125","author":"MZ Aumeeruddy","year":"2019","unstructured":"Aumeeruddy MZ, Mahomoodally MF (2019) Combating breast cancer using combination therapy with 3 phytochemicals: piperine, sulforaphane, and thymoquinone. Cancer 125(10):1600\u20131611. https:\/\/doi.org\/10.1002\/cncr.32022","journal-title":"Cancer"},{"issue":"9","key":"1225_CR7","first-page":"949","volume":"10","author":"JD Brooks","year":"2001","unstructured":"Brooks JD, Paton VG, Vidanes G (2001) Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 10(9):949\u2013954","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1225_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2017.02.023","volume":"394","author":"JP Burnett","year":"2017","unstructured":"Burnett JP, Lim G, Li Y, Shah RB, Lim R, Paholak HJ, McDermott SP, Sun L, Tsume Y, Bai S, Wicha MS, Sun D, Zhang T (2017) Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Lett 394:52\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.023","journal-title":"Cancer Lett"},{"key":"1225_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12929-015-0139-x","volume":"22","author":"CY Chen","year":"2015","unstructured":"Chen CY, Yu ZY, Chuang YS, Huang RM, Wang TC (2015) Sulforaphane attenuates EGFR signaling in NSCLC cells. J Biomed Sci 22:38. https:\/\/doi.org\/10.1186\/s12929-015-0139-x","journal-title":"J Biomed Sci"},{"issue":"1","key":"1225_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1208\/s12248-009-9162-8","volume":"12","author":"KL Cheung","year":"2010","unstructured":"Cheung KL, Kong AN (2010) Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. The AAPS Journal 12(1):87\u201397. https:\/\/doi.org\/10.1208\/s12248-009-9162-8","journal-title":"The AAPS Journal"},{"issue":"2","key":"1225_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1207\/s15327914nc5202_11","volume":"52","author":"SD Cho","year":"2005","unstructured":"Cho SD, Li G, Hu H, Jiang C, Kang KS, Lee YS, Kim SH, Lu J (2005) Involvement of c-Jun N-terminal kinase in G2\/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer 52(2):213\u2013224. https:\/\/doi.org\/10.1207\/s15327914nc5202_11","journal-title":"Nutr Cancer"},{"issue":"1","key":"1225_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/carcin\/bgl144","volume":"28","author":"S Choi","year":"2007","unstructured":"Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV (2007) D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 28(1):151\u2013162. https:\/\/doi.org\/10.1093\/carcin\/bgl144","journal-title":"Carcinogenesis"},{"key":"1225_CR13","unstructured":"Cipolla\u00a0BG,\u00a0Mandron\u00a0E,\u00a0Lefort JM, Coadou\u00a0Y,\u00a0Negra\u00a0ED,\u00a0Scodan\u00a0LCL,\u00a0Mottet N (2014) First double-blind placebo-controlled, multicenter, randomized trial of stabilized natural sulforaphane in men with rising PSA following radical prostatectomy. J Clin Oncol 32:5s. abstr 5032."},{"issue":"2","key":"1225_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.canlet.2008.04.018","volume":"269","author":"JD Clarke","year":"2008","unstructured":"Clarke JD, Dashwood RH, Ho E (2008) Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269(2):291\u2013304. https:\/\/doi.org\/10.1016\/j.canlet.2008.04.018","journal-title":"Cancer Lett"},{"issue":"7","key":"1225_CR15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/carcin\/bgm049","volume":"28","author":"BS Cornblatt","year":"2007","unstructured":"Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett-Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28(7):1485\u20131490. https:\/\/doi.org\/10.1093\/carcin\/bgm049","journal-title":"Carcinogenesis"},{"issue":"12","key":"1225_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1055\/s-0043-115905","volume":"67","author":"H Danafar","year":"2017","unstructured":"Danafar H, Sharafi A, Askarlou S, Manjili HK (2017a) Preparation and characterization of pegylated iron oxide-gold nanoparticles for delivery of sulforaphane and curcumin. Drug Res (Stuttg) 67(12):698\u2013704. https:\/\/doi.org\/10.1055\/s-0043-115905","journal-title":"Drug Res (Stuttg)"},{"issue":"5","key":"1225_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/10837450.2016.1146296","volume":"22","author":"H Danafar","year":"2017","unstructured":"Danafar H, Sharafi A, Manjili HK, Andalib S (2017b) Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells. Pharm Dev Technol 22(5):642\u2013651. https:\/\/doi.org\/10.3109\/10837450.2016.1146296","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"1225_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s13346-019-00619-0","volume":"9","author":"P Desai","year":"2019","unstructured":"Desai P, Thakkar A, Ann D, Wang J, Prabhu S (2019) Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer. Drug Deliv Transl Res 9(3):641\u2013651. https:\/\/doi.org\/10.1007\/s13346-019-00619-0","journal-title":"Drug Deliv Transl Res"},{"issue":"Pt B","key":"1225_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jconrel.2015.09.007","volume":"220","author":"SS Desale","year":"2015","unstructured":"Desale SS, Soni KS, Romanova S, Cohen SM, Bronich TK (2015) Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J Control Release 220(Pt B):651\u2013659. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.007","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1225_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2009.11.009","volume":"386","author":"DP Do","year":"2010","unstructured":"Do DP, Pai SB, Rizvi SA, D'Souza MJ (2010) Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. Int J Pharm 386(1\u20132):114\u2013121. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.11.009","journal-title":"Int J Pharm"},{"issue":"5","key":"1225_CR21","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3892\/or.2012.1977","volume":"28","author":"NA Doudican","year":"2012","unstructured":"Doudican NA, Wen SY, Mazumder A, Orlow SJ (2012) Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep 28(5):1851\u20131858. https:\/\/doi.org\/10.3892\/or.2012.1977","journal-title":"Oncol Rep"},{"key":"1225_CR22","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2147\/IJN.S43479","volume":"8","author":"GG Enriquez","year":"2013","unstructured":"Enriquez GG, Rizvi SAA, D\u2019Souza MJ, Do DP (2013) Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. Int J Nanomedicine 8:1393\u20131402. https:\/\/doi.org\/10.2147\/IJN.S43479","journal-title":"Int J Nanomedicine"},{"issue":"9\u201310","key":"1225_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0278-6915(99)00082-4","volume":"37","author":"JW Fahey","year":"1999","unstructured":"Fahey JW, Talalay P (1999) Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem Toxicol 37(9\u201310):973\u2013979","journal-title":"Food Chem Toxicol"},{"key":"1225_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600766","author":"JW Fahey","year":"2017","unstructured":"Fahey JW, Wade KL, Wehage SL, Holtzclaw WD, Liu H, Talalay P, Fuchs E, Stephenson KK (2017) Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/mnfr.201600766","journal-title":"Mol Nutr Food Res"},{"issue":"2\u20133","key":"1225_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mrrev.2006.10.004","volume":"635","author":"C Fimognari","year":"2007","unstructured":"Fimognari C, Hrelia P (2007) Sulforaphane as a promising molecule for fighting cancer. Mutat Res 635(2\u20133):90\u2013104. https:\/\/doi.org\/10.1016\/j.mrrev.2006.10.004","journal-title":"Mutat Res"},{"issue":"11","key":"1225_CR26","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1007\/PL00012523","volume":"59","author":"C Fimognari","year":"2002","unstructured":"Fimognari C, Nusse M, Berti F, Iori R, Cantelli-Forti G, Hrelia P (2002) Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes. Cell Mol Life Sci 59(11):2004\u20132012","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1225_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/03639045.2013.768634","volume":"40","author":"SJ Franklin","year":"2014","unstructured":"Franklin SJ, Dickinson SE, Karlage KL, Bowden GT, Myrdal PB (2014) Stability of sulforaphane for topical formulation. Drug Dev Ind Pharm 40(4):494\u2013502. https:\/\/doi.org\/10.3109\/03639045.2013.768634","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"1225_CR28","first-page":"1426","volume":"60","author":"L Gamet-Payrastre","year":"2000","unstructured":"Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60(5):1426\u20131433","journal-title":"Cancer Res"},{"key":"1225_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615\u2013627. https:\/\/doi.org\/10.1146\/annurev.med.53.082901.103929","journal-title":"Annu Rev Med"},{"issue":"10","key":"1225_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/1940-6207.capr-13-0172","volume":"6","author":"BK Grandhi","year":"2013","unstructured":"Grandhi BK, Thakkar A, Wang J, Prabhu S (2013) A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res (Phila) 6(10):1015\u20131025. https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0172","journal-title":"Cancer Prev Res (Phila)"},{"key":"1225_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jconrel.2015.09.029","volume":"219","author":"C He","year":"2015","unstructured":"He C, Lu J, Lin W (2015) Hybrid nanoparticles for combination therapy of cancer. J Control Release 219:224\u2013236. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.029","journal-title":"J Control Release"},{"issue":"10","key":"1225_CR32","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.7314\/APJCP.2013.14.10.5855","volume":"14","author":"A Hussain","year":"2013","unstructured":"Hussain A, Mohsin J, Prabhu SA, Begum S, Nusri QA, Harish G, Javed E, Khan MA, Sharma C (2013) Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine. Asian Pac J Cancer Prev 14(10):5855\u20135860","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"1225_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1534735411400313","volume":"11","author":"A Hussain","year":"2012","unstructured":"Hussain A, Priyani A, Sadrieh L, Brahmbhatt K, Ahmed M, Sharma C (2012) Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. Integr Cancer Ther 11(2):154\u2013165. https:\/\/doi.org\/10.1177\/1534735411400313","journal-title":"Integr Cancer Ther"},{"issue":"2","key":"1225_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia J, Zhu F, Ma X, Cao Z, Cao ZW, Li Y, Li YX, Chen YZ (2009) Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 8(2):111\u2013128. https:\/\/doi.org\/10.1038\/nrd2683","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1225_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11064-009-0040-7","volume":"35","author":"H Jiang","year":"2010","unstructured":"Jiang H, Shang X, Wu H, Huang G, Wang Y, Al-Holou S, Gautam SC, Chopp M (2010) Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem Res 35(1):152\u2013161. https:\/\/doi.org\/10.1007\/s11064-009-0040-7","journal-title":"Neurochem Res"},{"issue":"8","key":"1225_CR36","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/jf990082e","volume":"47","author":"Y Jin","year":"1999","unstructured":"Jin Y, Wang M, Rosen RT, Ho CT (1999) Thermal degradation of sulforaphane in aqueous solution. J Agric Food Chem 47(8):3121\u20133123","journal-title":"J Agric Food Chem"},{"issue":"4","key":"1225_CR37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3892\/ijo.2014.2536","volume":"45","author":"GH Jo","year":"2014","unstructured":"Jo GH, Kim GY, Kim WJ, Park KY, Choi YH (2014) Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway. Int J Oncol 45(4):1497\u20131506. https:\/\/doi.org\/10.3892\/ijo.2014.2536","journal-title":"Int J Oncol"},{"issue":"9","key":"1225_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00018-007-6484-5","volume":"64","author":"N Juge","year":"2007","unstructured":"Juge N, Mithen RF, Traka M (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64(9):1105\u20131127. https:\/\/doi.org\/10.1007\/s00018-007-6484-5","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1225_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/01635581.2015.1053498","volume":"67","author":"A Kaczynska","year":"2015","unstructured":"Kaczynska A, Swierczynska J, Herman-Antosiewicz A (2015) Sensitization of HER2 Positive Breast Cancer Cells to Lapatinib Using Plants-Derived Isothiocyanates. Nutr Cancer 67(6):976\u2013986. https:\/\/doi.org\/10.1080\/01635581.2015.1053498","journal-title":"Nutr Cancer"},{"issue":"1","key":"1225_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/mt.2010.216","volume":"19","author":"G Kallifatidis","year":"2011","unstructured":"Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, Moldenhauer G, B\u00fcchler MW, Salnikov AV, Herr I (2011) Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 19(1):188\u2013195. https:\/\/doi.org\/10.1038\/mt.2010.216","journal-title":"Mol Ther"},{"issue":"7","key":"1225_CR41","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/gut.2008.149039","volume":"58","author":"G Kallifatidis","year":"2009","unstructured":"Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G, Altevogt P, Wirth T, Werner J, Schemmer P, B\u00fcchler MW, Salnikov AV, Herr I (2009) Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 58(7):949\u2013963. https:\/\/doi.org\/10.1136\/gut.2008.149039","journal-title":"Gut"},{"issue":"1\u20132","key":"1225_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpharm.2018.01.045","volume":"539","author":"MM Kamal","year":"2018","unstructured":"Kamal MM, Nazzal S (2018a) Development of a new class of sulforaphane-enabled self-emulsifying drug delivery systems (SFN-SEDDS) by high throughput screening: a case study with curcumin. Int J Pharm 539(1\u20132):147\u2013156. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.045","journal-title":"Int J Pharm"},{"issue":"1","key":"1225_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2017.11.063","volume":"536","author":"MM Kamal","year":"2018","unstructured":"Kamal MM, Nazzal S (2018b) Novel sulforaphane-enabled self-microemulsifying delivery systems (SFN-SMEDDS) of taxanes: formulation development and in vitro cytotoxicity against breast cancer cells. Int J Pharm 536(1):187\u2013198. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.063","journal-title":"Int J Pharm"},{"issue":"5","key":"1225_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00280-010-1413-y","volume":"67","author":"BM Kaminski","year":"2011","unstructured":"Kaminski BM, Weigert A, Brune B, Schumacher M, Wenzel U, Steinhilber D, Stein J, Ulrich S (2011) Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death. Cancer Chemother Pharmacol 67(5):1167\u20131178. https:\/\/doi.org\/10.1007\/s00280-010-1413-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"1225_CR45","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuroscience.2006.04.075","volume":"141","author":"S Karmakar","year":"2006","unstructured":"Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK (2006) Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141(3):1265\u20131280. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.04.075","journal-title":"Neuroscience"},{"issue":"1","key":"1225_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mc.22714","volume":"57","author":"C Kerr","year":"2018","unstructured":"Kerr C, Adhikary G, Grun D, George N, Eckert RL (2018) Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Mol Carcinog 57(1):3\u201311. https:\/\/doi.org\/10.1002\/mc.22714","journal-title":"Mol Carcinog"},{"issue":"1\u20132","key":"1225_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.mrfmmm.2004.05.024","volume":"555","author":"YS Keum","year":"2004","unstructured":"Keum YS, Jeong WS, Kong AN (2004) Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat Res 555(1\u20132):191\u2013202. https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.05.024","journal-title":"Mutat Res"},{"issue":"21","key":"1225_CR50","first-page":"7520","volume":"63","author":"BR Kim","year":"2003","unstructured":"Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, Kong AN (2003) Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res 63(21):7520\u20137525","journal-title":"Cancer Res"},{"issue":"21","key":"1225_CR51","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1016\/j.biomaterials.2013.03.066","volume":"34","author":"JY Ko","year":"2013","unstructured":"Ko JY, Choi YJ, Jeong GJ, Im GI (2013) Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. Biomaterials 34(21):5359\u20135368. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.03.066","journal-title":"Biomaterials"},{"issue":"3\u20134","key":"1225_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1081\/dmr-120000652","volume":"33","author":"AN Kong","year":"2001","unstructured":"Kong AN, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S (2001) Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE\/EpRE). Drug Metab Rev 33(3\u20134):255\u2013271. https:\/\/doi.org\/10.1081\/dmr-120000652","journal-title":"Drug Metab Rev"},{"issue":"5","key":"1225_CR53","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3892\/ijo.2014.2335","volume":"44","author":"S Labsch","year":"2014","unstructured":"Labsch S, Liu L, Bauer N, Zhang Y, Aleksandrowicz E, Gladkich J, Sch\u00f6nsiegel F, Herr I (2014) Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells. Int J Oncol 44(5):1470\u20131480. https:\/\/doi.org\/10.3892\/ijo.2014.2335","journal-title":"Int J Oncol"},{"issue":"5","key":"1225_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jnc.13174","volume":"134","author":"F Lan","year":"2015","unstructured":"Lan F, Pan Q, Yu H, Yue X (2015) Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt\/beta-catenin signaling in glioblastoma. J Neurochem 134(5):811\u2013818. https:\/\/doi.org\/10.1111\/jnc.13174","journal-title":"J Neurochem"},{"key":"1225_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jbior.2018.11.006","volume":"71","author":"J Liang","year":"2019","unstructured":"Liang J, H\u00e4nsch GM, H\u00fcbner K, Samstag Y (2019) Sulforaphane as anticancer agent: a double-edged sword? Tricky balance between effects on tumor cells and immune cells. Adv Biol Regul 71:79\u201387. https:\/\/doi.org\/10.1016\/j.jbior.2018.11.006","journal-title":"Adv Biol Regul"},{"issue":"1","key":"1225_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/ijmm.2015.2199","volume":"36","author":"B Li","year":"2015","unstructured":"Li B, Kim DS, Yadav RK, Kim HR, Chae HJ (2015) Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells. Int J Mol Med 36(1):53\u201364. https:\/\/doi.org\/10.3892\/ijmm.2015.2199","journal-title":"Int J Mol Med"},{"issue":"1\u20132","key":"1225_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-012-1493-6","volume":"373","author":"SH Li","year":"2013","unstructured":"Li SH, Fu J, Watkins DN, Srivastava RK, Shankar S (2013) Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol Cell Biochem 373(1\u20132):217\u2013227. https:\/\/doi.org\/10.1007\/s11010-012-1493-6","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"1225_CR58","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/01635581.2011.596645","volume":"63","author":"Y Li","year":"2011","unstructured":"Li Y, Zhang T, Schwartz SJ, Sun D (2011) Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function. Nutr Cancer 63(7):1151\u20131159. https:\/\/doi.org\/10.1080\/01635581.2011.596645","journal-title":"Nutr Cancer"},{"issue":"2","key":"1225_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000439111","volume":"8","author":"K Lubecka-Pietruszewska","year":"2015","unstructured":"Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Cebula-Obrzut B, Smolewski P, Fabianowska-Majewska K (2015) Sulforaphane alone and in combination with clofarabine epigenetically regulates the expression of DNA methylation-silenced tumour suppressor genes in human breast cancer cells. J Nutrigenet Nutrigenomics 8(2):91\u2013101. https:\/\/doi.org\/10.1159\/000439111","journal-title":"J Nutrigenet Nutrigenomics"},{"issue":"17","key":"1225_CR60","first-page":"3649","volume":"57","author":"K Maheo","year":"1997","unstructured":"Maheo K, Morel F, Langouet S, Kramer H, Le FE, Ketterer B, Guillouzo A (1997) Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 57(17):3649\u20133652","journal-title":"Cancer Res"},{"issue":"3","key":"1225_CR48","doi-asserted-by":"publisher","first-page":"e0151344","DOI":"10.1371\/journal.pone.0151344","volume":"11","author":"HK Manjili","year":"2016","unstructured":"Manjili HK, Ma'mani L, Tavaddod S, Mashhadikhan M, Shafiee A, Naderi-Manesh H (2016) D, L-sulforaphane loaded Fe3O4@ gold core shell nanoparticles: a potential sulforaphane delivery system. PLoS ONE 11(3):e0151344. https:\/\/doi.org\/10.1371\/journal.pone.0151344","journal-title":"PLoS ONE"},{"issue":"8","key":"1225_CR49","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1080\/21691401.2017.1282501","volume":"45","author":"HK Manjili","year":"2017","unstructured":"Manjili HK, Sharafi A, Attari E, Danafar H (2017) Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL-PEG-PCL copolymeric-based micelles. Artif Cells Nanomed Biotechnol 45(8):1728\u20131739. https:\/\/doi.org\/10.1080\/21691401.2017.1282501","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1225_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2019.01.008","volume":"558","author":"L Mielczarek","year":"2019","unstructured":"Mielczarek L, Krug P, Mazur M, Milczarek M, Chilmonczyk Z, Wiktorska K (2019) In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes. Int J Pharm 558:311\u2013318. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.008","journal-title":"Int J Pharm"},{"key":"1225_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23113040","author":"M Milczarek","year":"2018","unstructured":"Milczarek M, Mielczarek L, Lubelska K, D\u0105browska A, Chilmonczyk Z, Matosiuk D, Wiktorska K (2018) In vitro evaluation of sulforaphane and a natural analog as potent inducers of 5-fluorouracil anticancer activity. Molecules. https:\/\/doi.org\/10.3390\/molecules23113040","journal-title":"Molecules"},{"issue":"1","key":"1225_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejmech.2005.10.002","volume":"41","author":"RM Moriarty","year":"2006","unstructured":"Moriarty RM, Naithani R, Kosmeder J, Prakash O (2006) Cancer chemopreventive activity of sulforamate derivatives. Eur J Med Chem 41(1):121\u2013124. https:\/\/doi.org\/10.1016\/j.ejmech.2005.10.002","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1225_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2005.02.033","volume":"233","author":"MC Myzak","year":"2006","unstructured":"Myzak MC, Dashwood RH (2006) Chemoprotection by sulforaphane: Keep one eye beyond Keap1. Cancer Lett 233(2):208\u2013218. https:\/\/doi.org\/10.1016\/j.canlet.2005.02.033","journal-title":"Cancer Lett"},{"issue":"2","key":"1225_CR65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11095-007-9364-7","volume":"25","author":"S Nair","year":"2008","unstructured":"Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, Kong AN (2008) Synergistic effects of a combination of dietary factors sulforaphane and (\u2212) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm Res 25(2):387\u2013399. https:\/\/doi.org\/10.1007\/s11095-007-9364-7","journal-title":"Pharm Res"},{"issue":"7","key":"1225_CR66","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1021\/jf051823g","volume":"54","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Umeda T, Higuchi O, Tsuzuki T, Suzuki T, Miyazawa T (2006) Evaporative light-scattering analysis of sulforaphane in broccoli samples: quality of broccoli products regarding sulforaphane contents. J Agric Food Chem 54(7):2479\u20132483. https:\/\/doi.org\/10.1021\/jf051823g","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1225_CR67","first-page":"92","volume":"6","author":"M Olempska","year":"2007","unstructured":"Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H (2007) Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 6(1):92\u201397","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"7","key":"1225_CR68","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/carcin\/bgm044","volume":"28","author":"G Pappa","year":"2007","unstructured":"Pappa G, Strathmann J, Lowinger M, Bartsch H, Gerhauser C (2007) Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro. Carcinogenesis 28(7):1471\u20131477. https:\/\/doi.org\/10.1093\/carcin\/bgm044","journal-title":"Carcinogenesis"},{"key":"1225_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061754","author":"B Paul","year":"2018","unstructured":"Paul B, Li Y, Tollefsbol TO (2018) The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19061754","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1225_CR70","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00394-015-0930-1","volume":"55","author":"A Pawlik","year":"2016","unstructured":"Pawlik A, Slominska-Wojewodzka M, Herman-Antosiewicz A (2016) Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants. Eur J Nutr 55(3):1165\u20131180. https:\/\/doi.org\/10.1007\/s00394-015-0930-1","journal-title":"Eur J Nutr"},{"issue":"1","key":"1225_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/jm00027a021","volume":"37","author":"GH Posner","year":"1994","unstructured":"Posner GH, Cho CG, Green JV, Zhang Y, Talalay P (1994) Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes. J Med Chem 37(1):170\u2013176","journal-title":"J Med Chem"},{"issue":"6","key":"1225_CR72","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3892\/etm.2010.144","volume":"1","author":"SJ Pradhan","year":"2010","unstructured":"Pradhan SJ, Mishra R, Sharma P, Kundu GC (2010) Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Exp Ther Med 1(6):915\u2013920. https:\/\/doi.org\/10.3892\/etm.2010.144","journal-title":"Exp Ther Med"},{"issue":"6","key":"1225_CR73","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1073\/pnas.89.6.2394","volume":"89","author":"HJ Prochaska","year":"1992","unstructured":"Prochaska HJ, Santamaria AB, Talalay P (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci USA 89(6):2394\u20132398","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1225_CR74","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1039\/c8fo01914b","volume":"10","author":"K Rakariyatham","year":"2019","unstructured":"Rakariyatham K, Yang X, Gao Z, Song M, Han Y, Chen X, Xiao H (2019) Synergistic chemopreventive effect of allyl isothiocyanate and sulforaphane on non-small cell lung carcinoma cells. Food Funct 10(2):893\u2013902. https:\/\/doi.org\/10.1039\/c8fo01914b","journal-title":"Food Funct"},{"issue":"12","key":"1225_CR75","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1158\/0008-5472.can-10-0066","volume":"70","author":"V Rausch","year":"2010","unstructured":"Rausch V, Liu L, Kallifatidis G, Baumann B, Mattern J, Gladkich J, Wirth T, Schemmer P, B\u00fcchler MW, Z\u00f6ller M, Salnikov AV, Herr I (2010) Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res 70(12):5004\u20135013. https:\/\/doi.org\/10.1158\/0008-5472.can-10-0066","journal-title":"Cancer Res"},{"issue":"1","key":"1225_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.yexcr.2018.04.015","volume":"368","author":"KJ Royston","year":"2018","unstructured":"Royston KJ, Paul B, Nozell S, Rajbhandari R, Tollefsbol TO (2018) Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. Exp Cell Res 368(1):67\u201374. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.015","journal-title":"Exp Cell Res"},{"key":"1225_CR77","doi-asserted-by":"publisher","first-page":"402386","DOI":"10.1155\/2015\/402386","volume":"2015","author":"P Sestili","year":"2015","unstructured":"Sestili P, Fimognari C (2015) Cytotoxic and antitumor activity of sulforaphane: the role of reactive oxygen species. BioMed Res Int 2015:402386. https:\/\/doi.org\/10.1155\/2015\/402386","journal-title":"BioMed Res Int"},{"issue":"3","key":"1225_CR78","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canep.2010.09.008","volume":"35","author":"C Sharma","year":"2011","unstructured":"Sharma C, Sadrieh L, Priyani A, Ahmed M, Hassan AH, Hussain A (2011) Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol 35(3):272\u2013278. https:\/\/doi.org\/10.1016\/j.canep.2010.09.008","journal-title":"Cancer Epidemiol"},{"issue":"20","key":"1225_CR79","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-07-1112","volume":"67","author":"G Shen","year":"2007","unstructured":"Shen G, Khor TO, Hu R, Yu S, Nair S, Ho CT, Reddy BS, Huang MT, Newmark HL, Kong AN (2007) Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin\/+. Cancer Res 67(20):9937\u20139944","journal-title":"Cancer Res"},{"issue":"1","key":"1225_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics 2018. CA Cancer J Clin 68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"1225_CR81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2015.05.028","volume":"86","author":"P Singh","year":"2015","unstructured":"Singh P, Sharma R, McElhanon K, Allen CD, Megyesi JK, Benes H, Singh SP (2015) Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med 86:90\u2013101. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.05.028","journal-title":"Free Radic Biol Med"},{"issue":"20","key":"1225_CR82","doi-asserted-by":"publisher","first-page":"19911","DOI":"10.1074\/jbc.M412443200","volume":"280","author":"SV Singh","year":"2005","unstructured":"Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 280(20):19911\u201319924. https:\/\/doi.org\/10.1074\/jbc.M412443200","journal-title":"J Biol Chem"},{"key":"1225_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/21691401.2017.1408124","volume":"46","author":"K Soni","year":"2018","unstructured":"Soni K, Rizwanullah M, Kohli K (2018) Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Artif Cells Nanomed Biotechnol 46:15\u201331. https:\/\/doi.org\/10.1080\/21691401.2017.1408124","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1225_CR84","doi-asserted-by":"publisher","first-page":"5438179","DOI":"10.1155\/2018\/5438179","volume":"2018","author":"X Su","year":"2018","unstructured":"Su X, Jiang X, Meng L, Dong X, Shen Y, Xin Y (2018) Anticancer activity of sulforaphane: the epigenetic mechanisms and the Nrf2 signaling pathway. Oxid Med Cell Longev 2018:5438179. https:\/\/doi.org\/10.1155\/2018\/5438179","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"1225_CR85","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3892\/ijo.2012.1636","volume":"41","author":"D Sutaria","year":"2012","unstructured":"Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S (2012) Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 41(6):2260\u20132268. https:\/\/doi.org\/10.3892\/ijo.2012.1636","journal-title":"Int J Oncol"},{"issue":"1\u20134","key":"1225_CR86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/biof.5520120102","volume":"12","author":"P Talalay","year":"2000","unstructured":"Talalay P (2000) Chemoprotection against cancer by induction of phase 2 enzymes. BioFactors 12(1\u20134):5\u201311","journal-title":"BioFactors"},{"issue":"4","key":"1225_CR87","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3892\/ijo.2015.2879","volume":"46","author":"A Thakkar","year":"2015","unstructured":"Thakkar A, Chenreddy S, Wang J, Prabhu S (2015) Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention. Int J Oncol 46(4):1827\u20131834. https:\/\/doi.org\/10.3892\/ijo.2015.2879","journal-title":"Int J Oncol"},{"key":"1225_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.carbpol.2015.01.003","volume":"122","author":"G Tian","year":"2015","unstructured":"Tian G, Li Y, Yuan Q, Cheng L, Kuang P, Tang P (2015) The stability and degradation kinetics of Sulforaphene in microcapsules based on several biopolymers via spray drying. Carbohydr Polym 122:5\u201310. https:\/\/doi.org\/10.1016\/j.carbpol.2015.01.003","journal-title":"Carbohydr Polym"},{"issue":"1","key":"1225_CR89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/ol.2017.7293","volume":"15","author":"F Wang","year":"2018","unstructured":"Wang F, Wang W, Li J, Zhang J, Wang X, Wang M (2018) Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling. Oncol Lett 15(1):109\u2013114. https:\/\/doi.org\/10.3892\/ol.2017.7293","journal-title":"Oncol Lett"},{"key":"1225_CR90","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4028\/www.scientific.net\/MSF.687.539","volume":"687","author":"H Wang","year":"2011","unstructured":"Wang H, Liang H, Yuan QP, Wang TX (2011) A novel pH-sensitive microsphere composed of CM-chitosan and alginate for sulforaphane delivery. Mater Sci Forum 687:539\u2013547. https:\/\/doi.org\/10.4028\/www.scientific.net\/MSF.687.539","journal-title":"Mater Sci Forum"},{"issue":"2","key":"1225_CR91","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4077\/cjp.2012.baa085","volume":"55","author":"M Wang","year":"2012","unstructured":"Wang M, Chen S, Wang S, Sun D, Chen J, Li Y, Han W, Yang X, Gao HQ (2012) Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer Caco-2 cells. Chin J Physiol 55(2):134\u2013144. https:\/\/doi.org\/10.4077\/cjp.2012.baa085","journal-title":"Chin J Physiol"},{"issue":"3","key":"1225_CR92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ptr.2618","volume":"23","author":"XF Wang","year":"2009","unstructured":"Wang XF, Wu DM, Li BX, Lu YJ, Yang BF (2009) Synergistic inhibitory effect of sulforaphane and 5-fluorouracil in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. Phytother Res 23(3):303\u2013307. https:\/\/doi.org\/10.1002\/ptr.2618","journal-title":"Phytother Res"},{"issue":"7","key":"1225_CR93","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.nutres.2015.05.011","volume":"35","author":"Y Wang","year":"2015","unstructured":"Wang Y, Dacosta C, Wang W, Zhou Z, Liu M, Bao Y (2015) Synergy between sulforaphane and selenium in protection against oxidative damage in colonic CCD841 cells. Nutr Res 35(7):610\u2013617. https:\/\/doi.org\/10.1016\/j.nutres.2015.05.011","journal-title":"Nutr Res"},{"key":"1225_CR94","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.bbamcr.2012.05.020","volume":"8","author":"A Wiczk","year":"1823","unstructured":"Wiczk A, Hofman D, Konopa G (1823) Herman-Antosiewicz A (2012) Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells. Biochim Biophys Acta 8:1295\u20131305. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.05.020","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1225_CR95","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.carbpol.2010.05.020","volume":"82","author":"H Wu","year":"2010","unstructured":"Wu H, Liang H, Yuan Q, Wang T, Yan X (2010) Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxypropyl-\u03b2-cyclodextrin. Carbohydr Polym 82(3):613\u2013617. https:\/\/doi.org\/10.1016\/j.carbpol.2010.05.020","journal-title":"Carbohydr Polym"},{"key":"1225_CR96","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.foodchem.2014.01.042","volume":"155","author":"Y Wu","year":"2014","unstructured":"Wu Y, Mao J, You Y, Liu S (2014a) Study on degradation kinetics of sulforaphane in broccoli extract. Food Chem 155:235\u2013239. https:\/\/doi.org\/10.1016\/j.foodchem.2014.01.042","journal-title":"Food Chem"},{"key":"1225_CR97","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.carbpol.2013.11.057","volume":"102","author":"Y Wu","year":"2014","unstructured":"Wu Y, Zou L, Mao J, Huang J, Liu S (2014b) Stability and encapsulation efficiency of sulforaphane microencapsulated by spray drying. Carbohydr Polym 102:497\u2013503. https:\/\/doi.org\/10.1016\/j.carbpol.2013.11.057","journal-title":"Carbohydr Polym"},{"key":"1225_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24193593","author":"Y Yagishita","year":"2019","unstructured":"Yagishita Y, Fahey JW, Dinkova-Kostova AT, Kensler TW (2019) Broccoli or sulforaphane: is it the source or dose that matters? Molecules. https:\/\/doi.org\/10.3390\/molecules24193593","journal-title":"Molecules"},{"key":"1225_CR99","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.antiviral.2015.11.008","volume":"125","author":"R Yamada","year":"2016","unstructured":"Yamada R, Suda H, Sadanari H, Matsubara K, Tuchida Y, Murayama T (2016) Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro. Antiviral Res 125:79\u201383. https:\/\/doi.org\/10.1016\/j.antiviral.2015.11.008","journal-title":"Antiviral Res"},{"issue":"7","key":"1225_CR100","first-page":"1982s","volume":"54","author":"CS Yang","year":"1994","unstructured":"Yang CS, Smith TJ, Hong JY (1986s) Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res 54(7):1982s\u20131986s","journal-title":"Cancer Res"},{"issue":"3","key":"1225_CR101","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ijc.21191","volume":"117","author":"V Yoxall","year":"2005","unstructured":"Yoxall V, Kentish P, Coldham N, Kuhnert N, Sauer MJ, Ioannides C (2005) Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: implications for its chemopreventive activity. Int J Cancer 117(3):356\u2013362. https:\/\/doi.org\/10.1002\/ijc.21191","journal-title":"Int J Cancer"},{"issue":"6","key":"1225_CR102","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1073\/pnas.89.6.2399","volume":"89","author":"Y Zhang","year":"1992","unstructured":"Zhang Y, Talalay P, Cho CG, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89(6):2399\u20132403","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1225_CR103","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1745-7254.2007.00679.x","volume":"28","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Tang L (2007) Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol Sin 28(9):1343\u20131354. https:\/\/doi.org\/10.1111\/j.1745-7254.2007.00679.x","journal-title":"Acta Pharmacol Sin"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-020-01225-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T01:17:08Z","timestamp":1615339028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-020-01225-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1007\/s12272-020-01225-2","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"16 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}